BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

CeNeS Pharmaceuticals plc

CeNeS launched its pharmaceutical business in late 2000 with the acquisition of three GlaxoWellcome products Diconal™, Cyclimorph™ and Valoid™. Diconal and Cyclimorph are strong analgesics used in the management of moderate to severe pain either by the oral route (Diconal) or the intravenous route (Cyclimorph). Cyclimorph contains morphine whereas Diconal contains the analgesic dipipanone. In both cases the analgesic is combined with cyclizine, a proven agent to counter the nausea and vomiting commonly associated with opioid analgesics. Valoid contains cyclizine as the sole active ingredient and is used to counter nausea and vomiting. These products have performed in line with expectations in 2001 and we expect further growth in 2002 based on an increased marketing effort. In September 2001 CeNeS launched Xefo® , a novel product for the treatment of post-operative pain, which had been in-licensed from Nycomed in January 2001. September 2001 also saw the establishment of CeNeS hospital sales force. Therefore, within twelve months of the acquisition of its first products from GlaxoWellcome CeNeS has successfully completed its aim of forming a small, focused pharma products sales and marketing division. Now that CeNeS has established a critical mass in this area, the plan is to acquire new products in the chosen areas of expertise to achieve maximum benefit from the infrastructure.


Contact Details:
Compass House, Vision Park, Chivers Way, Histon,
Cambridge
Cambridgeshire
CB4 9ZR
United Kingdom
Tel:+44(0)1223 266 466
Fax:+44(0)1223 266 467
Email:cenes@cenes.com
WWW:

www.cenes.com/




BioNews Results for CeNeS Pharmaceuticals plc:

Learn about the World CNS Therapeutics Market
Prudent Press Agency:  Sep 5 2008 1:11PM Matching: cenes pharmaceuticals plc
Learn about the World CNS Therapeutics Market
MarketWatch:  Sep 4 2008 11:02PM Matching: cenes pharmaceuticals plc
Learn about the World CNS Therapeutics Market
TMC Net:  Sep 4 2008 11:07PM Matching: cenes pharmaceuticals plc
Learn about the World CNS Therapeutics Market
NewsBlaze:  Sep 5 2008 6:04AM Matching: cenes pharmaceuticals plc
Learn about the World CNS Therapeutics Market
Houston Chronicle:  Sep 5 2008 5:38AM Matching: cenes pharmaceuticals plc
Promote your company here: BioNewsCast - Press Release Distribution

View more CeNeS Pharmaceuticals plc news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 182 times since April 2007, the link to the organisation's website has been followed 23 times

Recent Search Terms used to find this page: t | cenes.com | where can i buy valoid | cenes | DICONAL | cenes.com | .

Search for more companies in Cambridge

Search for more companies in Cambridgeshire



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for CeNeS Pharmaceuticals plc
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.